Cogent Biosciences Inc (COGT) — Capital Reinvestment Ratio

Latest as of December 2015: 0.11x

Cogent Biosciences Inc (COGT) has a Capital Reinvestment Ratio of 0.11x as of December 2015, meaning it reinvests 0% of its operating cash flow ($17.72 Million) in capital expenditures ($1.99 Million). Check Cogent Biosciences Inc (COGT) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

$17.72 Million
USD

Capital Expenditures

$1.99 Million
USD

Data as of

Dec 2015
Most recent filing

Cogent Biosciences Inc Capital Reinvestment Ratio (2015–2015)

This chart tracks Cogent Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see COGT operating cash flow.

Annual Capital Reinvestment Ratio for Cogent Biosciences Inc (2015–2015)

Year-by-year Capital Reinvestment Ratio for Cogent Biosciences Inc from 2015 to 2015. See Cogent Biosciences Inc (COGT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2015 0.11x $17.72 Million $1.99 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow